MeHg and plasma paraoxonase activity in Inuit of factors influencing the decreased HDL associated PON1 activity with aging. Exp Gerontol 39:59–66. Shaikh NA, Downar E. 1981. Time course of changes in porcine myocardial phospholipid levels during ischemia. A reas- sessment of the lysolipid hypothesis. Circ Res 49:316–325. Shih DM, Xia YR, Wang XP, Miller E, Castellani LW, Subbanagounder G, et al. 2000. Combined serum para- oxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis. J Biol Chem 275:17527–17535. Sorenson RC, Primo-Parmo SL, Kuo CL, Adkins S, Lockridge O, La Du BN. 1995. Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/arylesterase. Proc Natl Acad Sci USA 92:7187–7191. Stern AH. 2005. A review of the studies of the cardiovascular health effects of methylmercury with consideration of their suitability for risk assessment. Environ Res 98:133–142. Tremblay AJ, Morrissette H, Gagné JM, Bergeron J, Gagné C, Couture P. 2004. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 37:785–790. Varatharajalu R, Garige M, Leckey LC, Gong M, Lakshman MR. 2010. Betaine protects chronic alcohol and omega-3 PUFA-mediated down-regulations of PON1 gene, serum PON1 and homocysteine thiolactonase activities with res- toration of liver GSH. Alcohol Clin Exp Res 34:424–431. Yang WI, Lee SH, Ko YG, Kang SM, Choi D, Ha JW, et al. 2010. Relationship between paraoxonase-1 activity, carotid inti- ma-media thickness and arterial stiffness in hypertensive patients. J Hum Hypertens 24:492–494. Young TK, Bjerregaard P, Dewailly É, Risica PM, Jørgensen ME, Ebbesson SE. 2007. Prevalence of obesity and its metabolic correlates among the circumpolar Inuit in 3 countries. Am J Public Health 97:691–695. Environmental Health Perspectives • volume 119 | number 8 | August 2011 1083